Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
53.6M
-
Number of holders
-
232
-
Total 13F shares, excl. options
-
65.2M
-
Shares change
-
+8.42M
-
Total reported value, excl. options
-
$4.4B
-
Value change
-
+$507M
-
Put/Call ratio
-
1.15
-
Number of buys
-
164
-
Number of sells
-
-98
-
Price
-
$67.60
Significant Holders of SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) as of Q3 2025
323 filings reported holding SLNO - SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share as of Q3 2025.
SOLENO THERAPEUTICS INC - Common Stock, $0.001 par value per share (SLNO) has 232 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.2M shares
.
Largest 10 shareholders include FMR LLC (8M shares), JANUS HENDERSON GROUP PLC (6.06M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.9M shares), BlackRock, Inc. (3.49M shares), VANGUARD GROUP INC (2.81M shares), Avoro Capital Advisors LLC (2.58M shares), WELLINGTON MANAGEMENT GROUP LLP (2.31M shares), Vivo Capital, LLC (2.28M shares), STATE STREET CORP (2.17M shares), and Invesco Ltd. (1.5M shares).
This table shows the top 232 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.